Monday (05.10.2026)

08:00 – 09:15

Room: Großer Saal

Scientific Session Special Cases & Situations

  • Paul J. Bröckelmann
  • Josée Zijlstra
  • 08:00–08:20

    HL in Pregnancy

    • Anne-Sophie Robertz
  • 08:20–08:40

    Critical Organ Failure at Presentation

    • Hishan Tharmaseelan
  • 08:40–09:00

    Anti-PD1 Tx in Pre-Existing Autoimmune Disease

    • Yvonne Jauw
  • 09:00–09:15

    Workshop Report “Grassroot Initiative in Classic Hodgkin Lymphoma”

    • Ranjana Advani
    • Peter Omondi Oyiro

09:30 – 10:30

Room: Großer Saal

Scientific Session NLPHL

  • Richard Hoppe
  • Wolfram Klapper
  • 09:30–09:45

    Clinical Implications of Growth Patterns

    • Dennis Eichenauer
  • 09:45–10:05

    Treatment Strategies

    • Jamie Flerlage
  • 10:05–10:18

    Abstract T101: Single-Nuclei and Spatial Transcriptomic Analysis of Nodular Lymphocyte- Predominant Hodgkin Lymphoma (NLPHL)

    • Hua Dong
  • 10:18–10:30

    Abstract T102: Malignant LP cells build a stroma-poor, avascular niche that concentrates IDO1+ macrophages and excludes regulatory T cells in NLPHL and THRLBCL

    • Ilja Kalashnikov

10:45 – 12:15

Room: Großer Saal

Scientific Session Relapsed & Refractory HL

  • Craig H. Moskowitz
  • Anna Sureda
  • 10:45–11:05

    2L Treatment of HL in Era of Novel Agents

    • Alison Moskowitz
  • 11:05–11:20

    Revisiting the Role of Stem Cell Transplantation in rrHL

    • Bastian von Tresckow
  • 11:20–11:35

    Unmet Needs and Novel Treatment Approaches in >3L

    • Martin Hutchings
  • 11:35–11:48

    Abstract T106: Phase 1 PRIMAVERA Study of the PRMT5 Inhibitor AZD3470 in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma

    • Pier Luigi Zinzani
  • 11:48–12:01

    Abstract T107: Treatment patterns and survival outcomes of patients relapsing after frontline Nivolumab-AVD in advanced stage classical Hodgkin lymphoma (cHL)

    • Harsh Shah
  • 12:01–12:15

    Abstract T108: Primary Analysis of the GHSG Pembro-CORE Trial: PET-Adapted PD-1-Based Salvage Therapy Omitting High-Dose Chemotherapy in First-Relapsed Hodgkin Lymphoma

    • Hishan Tharmaseelan

12:15 – 13:00

Room: Großer Saal

Main Program Best of ISHL14

  • 12:15–12:45

    Best of ISHL14

    • Ranjana Advani
  • 12:45–13:00

    Farewell

    • Peter Borchmann

ISHL14 Final Program

ISHL14 Final Program

Save the date

Save the event to your calendar

ISHL14: Program at a Glance

ISHL14: Program at a Glance

Archive

You can explore the ISHL13 program to get an impression of the broad spectrum and diversity of the congress.